# Phase III Trial of Febuxostat in Korea Gout Patients

> **NCT00821392** · PHASE3 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 181 (actual)

## Conditions studied

- Gout

## Interventions

- **DRUG:** Febuxostat

## Key facts

- **NCT ID:** NCT00821392
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 181 (ACTUAL)
- **Last updated:** 2009-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00821392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00821392, "Phase III Trial of Febuxostat in Korea Gout Patients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00821392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*